跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mupirtect - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mupirtect
Approved
STANDARD
Mupirtect
Orbit Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fcb212368eafc9e6
Company
Orbit Pharmaceuticals
Type
Standard
Approval Details
Approval Id
fcb212368eafc9e6
Drug Approval Philippines Name
Mupirtect
Product Name
Mupirtect
Registration Number
DRP-16295
Brand Name
Mupirtect
Generic Name
Mupirocin
Dosage Form
Topical Ointment
Dosage Strength
20 mg/g (2% w/w)
Manufacturer
Orbit Pharmaceuticals
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
28 January 2025
Expiry Date
28 January 2030
Pharmacologic Category
Antibacterial
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fcb212368eafc9e6
Type
Standard
Back to Philippines FDA Approvals